Radiopharm Theranostics (ASX:RAD) has achieved a milestone in its ongoing clinical development program for its radiotherapeutic asset, 177Lu-RAD204. …
Radiopharm Theranostics accelerates 177Lu-RAD204 Phase 1 dose escalation trial
May 12, 2025 Australian Biotech
Latest Video
New Stories
-
Monash scientists secure MRFF funding to find new medicines for dementia by 'lighting up' human brain cells
May 12, 2025 - -
Radiopharm Theranostics accelerates 177Lu-RAD204 Phase 1 dose escalation trial
May 12, 2025 - - Australian Biotech -
An already busy fixed ministerial bandwidth, just got much busier
May 12, 2025 - - Latest News -
Australian nursing leader makes the finalist list of global award
May 11, 2025 - - Latest News -
Australia has been managing the risk of international reference pricing for most of this century
May 11, 2025 - - Latest News -
Pharmac funds and widens access to melanoma medicines
May 11, 2025 - - Latest News -
Non-descript vagueness on pharmaceuticals in US-UK bilateral trade agreement
May 11, 2025 - - Latest News